149 related articles for article (PubMed ID: 5247)
1. Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
Kasich AM
Curr Ther Res Clin Exp; 1976 Mar; 19(3):292-306. PubMed ID: 5247
[No Abstract] [Full Text] [Related]
2. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
Berkowitz JM
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
[TBL] [Abstract][Full Text] [Related]
3. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
Hart WL; Parmley LF
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
[TBL] [Abstract][Full Text] [Related]
4. Clinical assessment of lorazepam in anxiety: a double-blind study.
Olgiati SG
Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
[No Abstract] [Full Text] [Related]
5. A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice [proceedings].
Lipman R; Vanov SK; Richards DJ
Psychopharmacol Bull; 1977 Apr; 13(2):17-9. PubMed ID: 16308
[No Abstract] [Full Text] [Related]
6. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
Stokes DK
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
[TBL] [Abstract][Full Text] [Related]
7. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
Finkel S
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
[TBL] [Abstract][Full Text] [Related]
8. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study.
Ananth V; Beszterczy A; Geagea C
Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825
[No Abstract] [Full Text] [Related]
9. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
Fischer-Cornelssen KA
Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092
[No Abstract] [Full Text] [Related]
10. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
Bertin I; Colombo G; Furlanut M; Benetello P
Int J Clin Pharmacol Res; 1989; 9(3):203-8. PubMed ID: 2568350
[TBL] [Abstract][Full Text] [Related]
11. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
[TBL] [Abstract][Full Text] [Related]
12. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
Pinosky DG
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
[TBL] [Abstract][Full Text] [Related]
13. Lorazepam in gastrointestinal disorders with anxiety overlay.
Furtado JD
Psychosomatics; 1976; 17(1):32-4. PubMed ID: 5745
[No Abstract] [Full Text] [Related]
14. Chlorazepate dipotassium in the treatment of anxiety associated with chronic gastrointestinal disease.
Kasich AM
Curr Ther Res Clin Exp; 1973 Mar; 15(3):83-91. PubMed ID: 4196231
[No Abstract] [Full Text] [Related]
15. Clinical profile of lorazepam, a new benzodiazepine tranquilizer.
Richards DJ
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):58-66. PubMed ID: 30770
[No Abstract] [Full Text] [Related]
16. Evaluation of the safety and therapeutic effects of lorazepam on long-term use.
Siassi I; Thomas M; Vanov SK
Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):163-71. PubMed ID: 240649
[No Abstract] [Full Text] [Related]
17. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
McCurdy L; Schatzberg AF
J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
[TBL] [Abstract][Full Text] [Related]
18. Lorazepam in anxiety with GI disorders.
Rider JA
Psychosomatics; 1977 Aug; 18(3):55-8. PubMed ID: 19808
[No Abstract] [Full Text] [Related]
19. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
20. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
Cohn JB; Wilcox CS
J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
